IPO Calendar

• Upcoming
• Recent

PRPH

ProPhase Labs

Follow-on

Anticipated date

19.01.2021

Сlosing price

$16

We are a diversified medical science and technology company with deep experience with OTC consumer healthcare products and dietary supplements.

FOXWU

FoxWayne Enterprises Acquisition Corp

IPO

Anticipated date

20.01.2021

Anticipated price

$10 - $10

SPAC Offering: This is an initial public offering of our securities. Each unit has an offering price of $10.00 and consists of one share of our Class A common stock and one redeemable warrant.

HUDI

Huadi International Group

IPO

Anticipated date

22.01.2021

Anticipated price

$7 - $8

Our main business operation focuses on new products development, manufacturing, marketing and sales of stainless steel seamless pipes, tubes and stainless steel bar.

PDO

PIMCO Dynamic Income Opportunities Fund

IPO

Anticipated date

27.01.2021

Anticipated price

$20 - $20

Closed End Fund: The Fund seeks current income as a primary objective and capital appreciation as a secondary objective.

Get analytical
overview on IPO

Invalid field format

First name*

Last name*

Email*

Phone*

Invalid telephone number

* Required fields

I confirm that I agree with the Privacy Policy and the Terms and Conditions that apply to the use of this website and any services provided hereto *

Get overview

×

LTRN

Lantern Pharma

Follow-on

Anticipated date

15.01.2021

Сlosing price

$18.2

We are a clinical stage biotechnology company, focused on leveraging artificial intelligence (“A.I.”), machine learning and genomic data to streamline the drug development process and to identify the patients that will benefit from our targeted oncology therapies.

PRVB

Provention Bio

Follow-on

Anticipated date

14.01.2021

Сlosing price

$17.7

We are a clinical stage biopharmaceutical company, focused on the development and commercialization of novel therapeutics and innovative approaches aimed at intercepting and preventing immune-mediated diseases.

HCDI

Harbor Custom Development

Follow-on

Anticipated date

13.01.2021

Сlosing price

$4.35

We are a real estate development company involved in all aspects of the land development cycle including, land acquisition, entitlements, construction of project infrastructure, home building, marketing, sales, and management of various residential projects in Western Washington’s Puget Sound region.

QLI

Qilian International Holding Group

IPO

Anticipated date

12.01.2021

Anticipated price

$5 - $7

We are a pharmaceutical and chemical company based in China that focuses on the development, manufacture, marketing, and sale of licorice products, oxytetracycline products, traditional Chinese medicine derivatives (“TCMD”) product, heparin product, sausage casings, and fertilizers.

BCYPU

Big Cypress Acquisition

IPO

Anticipated date

12.01.2021

Anticipated price

$10 - $10

Big Cypress Acquisition Corp. is a newly organized blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination, which we refer to as our initial business combination, with one or more businesses, which we refer to as target businesses. We have not selected any specific target business and we have not, nor has anyone on our behalf, initiated any substantive discussions, directly or indirectly, with any target business with respect to an initial business combination with our company. While we may pursue a target business in any industry or sector, we intend to focus our search on companies in the life sciences industry.

FRGAP

Franchise Group, Inc.

Follow-on

Anticipated date

12.01.2021

Сlosing price

$25.21

Series A Cumulative Perpetual Preferred Stock: We are a retailer, franchisor operator and acquirer of franchised and franchisable businesses that can be scaled using our operating philosophies. We currently operate four reportable segments: Liberty Tax, Buddy’s, American Freight, and Vitamin Shoppe.

IKT

Inhibikase Therapeutics

IPO

Anticipated date

23.12.2020

Anticipated price

$10 - $12

We are a clinical stage pharmaceutical company developing therapeutics for Parkinson’s Disease, or PD, and related disorders that arise inside and outside of the brain.

CSSEN

Chicken Soup for the Soul Entertainment

Follow-on

Anticipated date

18.12.2020

Сlosing price

$24.93

9.5% notes due 2025

VIRI

Virios Therapeutics

IPO

Anticipated date

17.12.2020

Anticipated price

$9 - $11

We are a development-stage biotechnology company focused on advancing novel antiviral therapies to treat diseases associated with a viral triggered abnormal immune response, such as fibromyalgia (“FM”).

SCPS

Scopus BioPharma

IPO

Anticipated date

16.12.2020

Anticipated price

$5.25 - $5.75

We are a biopharmaceutical company developing transformational therapeutics targeting serious diseases with significant unmet medical needs.

FAQ

• What is an IPO?
  An Initial Public Offering (IPO) is the first time that the stock of a private company is offered to the public. Companies go public for a variety of reasons: to raise capital for financing business plans and growth opportunities, to provide liquidity to investors and employees, and to use stock as a currency for mergers and acquisitions.
• Why to invest in IPO?
  An IPO is an opportunity to make a ground floor investment at the IPO price before the stock starts trading on the exchange.
• What is a Follow-on offering?
  A Follow-on Offering (FPO) is when an already public company registers additional shares. The shares could be newly issued by the company to raise additional capital or a sale by an existing shareholder, or both. Most Follow-on Offerings are priced below the closing price of the stock to create an incentive for investors.
• How do I participate in an IPO/FPO through Just2Trade?
  Open MT5 Global account, fund it and place an order for participation in the offering that is of interest to you in the Private Office.
• What are the fees and terms of participation?
  The minimum order size equals 1 000 US dollars. Participation fee is 4% of the allocated amount and is charged from your brokerage account upon the allocation of shares.
• Why are orders placed in dollars instead of shares?
  Orders are placed in dollars because the final price of the offering is not determined until the offering is effective. Allocation will be in shares. Regardless of the final price, you will not be allocated more shares than the total dollar amount of your order.
• How is the offering price determined?

  The offering price is determined by the underwriter and is normally based on numerous factors such as company’s financials, its future perspectives and risks, as well as demand for the company shares.

  The price determined should be high enough for the company to raise sufficient capital, while representing a fair value of the shares for potential investors.
• How are the shares allocated?
  After the issue is priced, shares will be distributed among accounts that have placed orders and met all other conditions for participation. You could be allocated the entire dollar amount of your order, part of your order, or none of your order. Once the shares have been allocated, you will be able to view your position in your MT5 Global account.
• When can I sell allocated shares?
  You are free to sell shares any time after allocation takes place, yet please note that selling shares within 30 calendar days (lock-up period) from the date the IPO was initially publicly traded entails a fee of 1.75% of transaction amount.